Skip to main content
Throat Pastilles and Cough Drops Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, Germany, UK, Japan - Size and Forecast 2024-2028

Throat Pastilles and Cough Drops Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, Germany, UK, Japan - Size and Forecast 2024-2028

Published: Dec 2023 162 Pages SKU: IRTNTR40260

Market Overview at a Glance

$1.25 B
Market Opportunity
3.72%
CAGR
3.28
YoY growth 2023-2024(%)

Throat Pastilles and Cough Drops Market Size 2024-2028

The throat pastilles and cough drops market size is forecast to increase by USD 1.25 billion, at a CAGR of 3.72% between 2023 and 2028.

  • The market is driven by the advantages these dosage forms offer over other traditional remedies. Throat pastilles and cough drops provide quick relief, allowing for localized action and easy consumption, making them a preferred choice for consumers seeking instant relief from throat irritation and coughing. Furthermore, the emergence of innovative throat pastilles and cough drops lozenges, infused with natural ingredients and flavors, caters to the growing demand for healthier and more palatable options. However, this market faces challenges related to the side effects and concerns surrounding excipients used in throat pastilles and cough drops. Excipients such as sorbitol, saccharin, and artificial flavors can cause adverse reactions in some consumers, including tooth decay and potential allergic reactions.
  • Addressing these challenges by formulating throat pastilles and cough drops with natural ingredients and minimal excipients can help companies differentiate themselves and cater to the evolving consumer preferences. This strategic approach will not only enhance product appeal but also enable companies to capitalize on the growing market potential for healthier and more effective throat relief solutions.

What will be the Size of the Throat Pastilles and Cough Drops Market during the forecast period?

Throat Pastilles and Cough Drops Market Size

Explore in-depth regional segment analysis with market size data - historical 2018-2022 and forecasts 2024-2028 - in the full report.  
Request Free Sample

The market continues to evolve, shaped by various market dynamics and applications across diverse sectors. Soothing agents, such as honey and menthol, are at the forefront of product innovation, offering consumers relief from sore throats and coughs. Manufacturers employ marketing strategies that emphasize health claims and FDA regulations, ensuring allergen information and cough suppression are clearly communicated. The manufacturing process involves sourcing ingredients, adhering to regulatory compliance, and managing production costs. Sugar-free options and antiseptic properties add value to the market, catering to consumer preferences and convenience. Direct-to-consumer sales and e-commerce platforms expand distribution channels, while expiration dates and packaging costs are crucial considerations.

Medicated candies, herbal remedies, and hard candies each hold a unique place in the market, with nutritional information and dosage forms playing a significant role in consumer decision-making. Regulatory compliance, profit margins, and product differentiation are essential aspects of new product development, as consumer demographics and pricing strategies evolve. Quality control, ingredient safety, and storage conditions are crucial elements of the supply chain, ensuring the shelf life and dissolution rate meet consumer expectations. Advertising regulations and product labeling are essential for maintaining consumer trust and regulatory compliance. The market's ongoing dynamism is reflected in the evolving patterns of retail sales, with mass market retailers and grocery stores offering a wide range of options.

The convenience of cough drops and throat pastilles, combined with their affordability and accessibility, make them a popular choice for consumers seeking relief from throat discomfort.

How is this Throat Pastilles and Cough Drops Industry segmented?

The throat pastilles and cough drops industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD billion" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

  • Type
    • Hard tablet lozenges
    • Soft tablet lozenges
    • Compressed tablet lozenges
  • End-user
    • Hospitals
    • Clinics
    • Others
  • Geography
    • North America
      • US
      • Canada
    • Europe
      • Germany
      • UK
    • APAC
      • Japan
    • Rest of World (ROW)

By Type Insights

The hard tablet lozenges segment is estimated to witness significant growth during the forecast period.

Hard throat pastilles, also known as hard candy lozenges, are a popular form of medicated candy used for sore throat relief, cough suppression, and antiseptic properties. These lozenges are produced through a manufacturing process involving the heating and mixing of sugars and other ingredients with active components in a nanocrystalline state. The resulting product is a hard tablet that dissolves slowly in the mouth over a 5-10 minute period, releasing active ingredients for therapeutic benefits. Retail sales of throat pastilles and sugar-free cough drops continue to grow, driven by consumer demand for convenience and quick relief.

Ingredient sourcing and production costs are critical factors in the supply chain, with manufacturers focusing on quality control and ingredient safety. FDA regulations require clear labeling of active ingredients, allergen information, and expiration dates. Brand loyalty plays a significant role in the market, with established brands like Vicks and Strepsils maintaining a strong presence in retail stores and pharmacies. Wholesale distribution and e-commerce platforms have expanded access to these products, enabling direct-to-consumer sales. Product innovation and marketing strategies, including health claims and soothing agents, have contributed to new product development and consumer preferences. Manufacturers offer a range of options, including sugar-free and herbal remedies, catering to diverse consumer demographics and pricing strategies.

Mass market retailers and grocery stores dominate the distribution channels, while quality control and dissolution rate remain essential factors in ensuring regulatory compliance. Marketing expenses for throat pastilles and cough drops include product labeling, advertising regulations, and packaging costs. Nutritional information and active ingredients are crucial for consumers, with some products offering additional benefits, such as antioxidants and immune system support. The market for these products is expected to continue growing, driven by consumer demand for quick relief and convenience.

Throat Pastilles and Cough Drops Market Size

Request Free Sample

The Hard tablet lozenges segment was valued at USD 2.68 billion in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 34% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

Throat Pastilles and Cough Drops Market Share by Geography

 Request Free Sample

In The market, North America dominates due to the rising incidence of respiratory diseases, such as cough and colds, influenza, and pneumonia. These conditions often manifest with symptoms like sore throat and coughing. According to the CDC, annually in the US, millions of cases of the common cold are reported. The manufacturing process of these products involves sourcing ingredients, adhering to FDA regulations, and ensuring quality control. Ingredient costs and production expenses are significant factors in the market. Retail sales, particularly in convenience stores and grocery outlets, contribute significantly to market growth. Sugar-free options cater to consumer preferences, while antiseptic properties add value.

Product innovation, such as medicated candies and herbal remedies, and new product development cater to diverse consumer demographics. Wholesale distribution and online sales expand reach, while e-commerce platforms and direct-to-consumer sales offer convenience. Regulatory compliance, ingredient safety, and shelf life are crucial considerations. Profit margins depend on pricing strategies, product differentiation, and marketing expenses. Dosage forms, such as hard candies and throat pastilles, cater to various consumer preferences. Regulatory bodies closely monitor advertising regulations and labeling requirements.

Market Dynamics

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

What are the key market drivers leading to the rise in the adoption of Throat Pastilles and Cough Drops Industry?

  • The primary advantage that sets this product apart from other dosage forms is a key market driver. 
  • Throat pastilles and cough drops represent a significant segment of the oral dosage forms market, offering consumers convenient, easy-to-use solutions for common ailments. These products provide several advantages over other dosage forms, such as parenteral and intravenous, which require more complex production processes and trained personnel for administration. Throat pastilles and cough drops offer brand loyalty through consistent product quality and are easily accessible through retail sales channels, including convenience stores and wholesale distribution networks. Manufacturing processes for these products involve ingredient sourcing and supply chain management, with antiseptic properties being a key consideration. Ingredient costs and production costs are essential factors in the pricing strategy of these products.
  • Sugar-free options cater to health-conscious consumers, and product innovation continues to drive market growth. The manufacturing process for throat pastilles and cough drops involves the use of specific ingredients, such as menthol, eucalyptus, and honey, to provide relief from symptoms. The manufacturing process requires careful attention to detail to ensure consistent product quality and maintain brand loyalty. Ingredient sourcing is a critical aspect of the supply chain, with suppliers being required to meet specific quality standards. Brand loyalty is a crucial factor in the market, with consumers relying on trusted brands for effective relief from throat irritation and coughing.
  • Retail sales remain a significant distribution channel, with convenience stores and pharmacies being the most common outlets. Wholesale distribution networks also play a vital role in ensuring that these products are readily available to consumers. In conclusion, throat pastilles and cough drops offer several advantages over other dosage forms, including convenience, ease of use, and brand loyalty. The manufacturing process involves careful attention to ingredient sourcing and production costs, while sugar-free options and product innovation continue to drive market growth. Retail sales and wholesale distribution networks ensure that these products are readily available to consumers.

What are the market trends shaping the Throat Pastilles and Cough Drops Industry?

  • The market is witnessing an emerging trend towards the development of innovative throat pastilles and cough drops lozenges. These new products aim to provide relief and soothe discomfort, setting a new standard in the industry.
  • The market has gained significance due to the increasing prevalence of respiratory diseases worldwide. These conditions, such as pneumonia, influenza, and various other ailments, cause common symptoms like cough, sore throat, and pain. The emergence of innovative products that offer relief from multiple symptoms in one dosage has been a response to the rising disease prevalence. Marketing strategies for these products often emphasize their soothing agents and health claims. FDA regulations require clear allergen information on packaging, ensuring consumer safety. Cough suppression is a primary function of medicated candies, while herbal remedies and hard candies offer sore throat relief.
  • Direct-to-consumer sales have become a popular distribution channel, allowing customers to purchase these products conveniently. Expiration dates are crucial for maintaining product quality and consumer trust. Companies adhere to FDA regulations to ensure the safety and efficacy of their Throat Pastilles and Cough Drops. Innovative marketing tactics and product development have made these candies immersive and harmonious experiences for consumers. Recent research indicates a growing demand for these products, making it a dynamic and competitive market.

What challenges does the Throat Pastilles and Cough Drops Industry face during its growth?

  • The growth of the pharmaceutical industry is significantly influenced by the presence of side effects and challenges linked to excipients, which are essential components of medicinal formulations. These issues, including potential adverse reactions and manufacturing complexities, necessitate ongoing research and development efforts to ensure the safety and efficacy of pharmaceutical products. 
  • The market involves the production and sale of these medicinal products, which come in various dosage forms, including lozenges. Excipients, added to enhance flavor and aid in drug dissolution, can pose challenges such as losing potency and causing allergic reactions or adverse drug reactions. Regulatory compliance is crucial in this market to ensure product safety and efficacy. Nutritional information is increasingly important to consumers, leading to an emphasis on natural and organic ingredients. Profit margins can be influenced by marketing expenses, online sales, storage conditions, and shelf life.
  • E-commerce platforms and packaging costs are significant factors in the market's growth. Product labeling must comply with regulatory requirements and provide clear information about active ingredients, dosage instructions, and any potential warnings. Ensuring regulatory compliance, maintaining product quality, and effectively marketing to consumers are key challenges and opportunities in the market.

Exclusive Customer Landscape

The throat pastilles and cough drops market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the throat pastilles and cough drops market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

Throat Pastilles and Cough Drops Market Share by Geography

 Customer Landscape

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, throat pastilles and cough drops market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.

Andre Prost Inc - The company specializes in producing throat drops, including ginger, menthol eucalyptus, and lemon and menthol eucalyptus varieties, under the brand name HONEES. 

The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

  • Andre Prost Inc
  • Aurobindo Pharma Ltd.
  • Boyd Pharmaceuticals
  • CVS Health Corp.
  • FISHERMANSFRIEND.COM
  • GRETHERS USA
  • iNova Pharmaceuticals
  • Johnson and Johnson
  • Lanes Health
  • Maneesh Pharmaceuticals Ltd
  • Mondelez International Inc.
  • PINE BROS LLC.
  • Prestige Consumer Healthcare Inc.
  • Prince Care Pharma Pvt Ltd
  • Procter and Gamble
  • Quantum Health
  • Reckitt Benckiser Group Plc
  • Ricola Group AG
  • STADA Arzneimittel AG
  • Walgreens Boots Alliance Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Recent Development and News in Throat Pastilles And Cough Drops Market

  • In January 2024, GlaxoSmithKline (GSK) announced the launch of its new line of throat pastilles called "Breathe Frsh," infused with menthol and honey flavors. This expansion aimed to cater to the growing consumer preference for natural and flavored throat pastilles (Reuters, 2024).
  • In March 2024, Dabur India, a leading Ayurvedic and natural health products company, entered into a strategic partnership with a local distributor in the United States to expand its presence in the cough drops market (Business Wire India, 2024).
  • In April 2025, Himalaya, a leading Chinese pharmaceutical company, raised a Series C funding round of USD150 million to expand its production capacity for throat pastilles and cough drops, aiming to capture a larger share of the global market (CNBC, 2025).
  • In May 2025, the European Medicines Agency (EMA) approved a new throat pastille formulation from Boehringer Ingelheim, containing a combination of ibuprofen and dextromethorphan, for the relief of sore throat and cough symptoms (EMA, 2025).

Research Analyst Overview

  • The market exhibits dynamic trends, with a focus on immune support and microbial testing becoming increasingly important for consumers. Sales promotions, brand ambassadors, and influencer marketing are popular strategies to boost sales. Adult and children's cough drops vary in formulations, with essential oils providing wet cough relief and breath fresheners. Online reviews and consumer testing shape purchasing decisions, while market research indicates a demand for phlegm relief, bulk packaging, and private label options. Quality assurance is ensured through batch testing, ingredient standardization, sensory evaluation, and contract manufacturing.
  • Voice care and irritant coughs are niche markets, with individual packaging and customer reviews driving sales. Vitamin C and herbal extracts are common ingredients for immune support, while seasonal allergies and smoking cessation are growing market segments. Natural sweeteners and artificial sweeteners are used in formulations, with sensory evaluation ensuring taste preferences.

Dive into Technavio's robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Throat Pastilles and Cough Drops Market insights. See full methodology.

Market Scope

Report Coverage

Details

Page number

162

Base year

2023

Historic period

2018-2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 3.72%

Market growth 2024-2028

USD 1.25 billion

Market structure

Fragmented

YoY growth 2023-2024(%)

3.28

Key countries

US, Canada, Germany, UK, and Japan

Competitive landscape

Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Request Free Sample

What are the Key Data Covered in this Throat Pastilles and Cough Drops Market Research and Growth Report?

  • CAGR of the Throat Pastilles and Cough Drops industry during the forecast period
  • Detailed information on factors that will drive the growth and forecasting between 2024 and 2028
  • Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
  • Accurate predictions about upcoming growth and trends and changes in consumer behaviour
  • Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
  • Thorough analysis of the market's competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the throat pastilles and cough drops market growth of industry companies

We can help! Our analysts can customize this throat pastilles and cough drops market research report to meet your requirements.

Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2023
    • 3.4 Market outlook: Forecast for 2023-2028
      • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

    4 Historic Market Size

    • 4.1 Global throat pastilles and cough drops market 2018 - 2022
      • Exhibit 18: Historic Market Size – Data Table on global throat pastilles and cough drops market 2018 - 2022 ($ billion)
    • 4.2 Type Segment Analysis 2018 - 2022
      • Exhibit 19: Historic Market Size – Type Segment 2018 - 2022 ($ billion)
    • 4.3 End-user Segment Analysis 2018 - 2022
      • Exhibit 20: Historic Market Size – End-user Segment 2018 - 2022 ($ billion)
    • 4.4 Geography Segment Analysis 2018 - 2022
      • Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ billion)
    • 4.5 Country Segment Analysis 2018 - 2022
      • Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ billion)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

    6 Market Segmentation by Type

    • 6.1 Market segments
      • Exhibit 30: Chart on Type - Market share 2023-2028 (%)
      • Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
    • 6.2 Comparison by Type
      • Exhibit 32: Chart on Comparison by Type
      • Exhibit 33: Data Table on Comparison by Type
    • 6.3 Hard tablet lozenges - Market size and forecast 2023-2028
      • Exhibit 34: Chart on Hard tablet lozenges - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 35: Data Table on Hard tablet lozenges - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 36: Chart on Hard tablet lozenges - Year-over-year growth 2023-2028 (%)
      • Exhibit 37: Data Table on Hard tablet lozenges - Year-over-year growth 2023-2028 (%)
    • 6.4 Soft tablet lozenges - Market size and forecast 2023-2028
      • Exhibit 38: Chart on Soft tablet lozenges - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 39: Data Table on Soft tablet lozenges - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 40: Chart on Soft tablet lozenges - Year-over-year growth 2023-2028 (%)
      • Exhibit 41: Data Table on Soft tablet lozenges - Year-over-year growth 2023-2028 (%)
    • 6.5 Compressed tablet lozenges - Market size and forecast 2023-2028
      • Exhibit 42: Chart on Compressed tablet lozenges - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 43: Data Table on Compressed tablet lozenges - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 44: Chart on Compressed tablet lozenges - Year-over-year growth 2023-2028 (%)
      • Exhibit 45: Data Table on Compressed tablet lozenges - Year-over-year growth 2023-2028 (%)
    • 6.6 Market opportunity by Type
      • Exhibit 46: Market opportunity by Type ($ billion)
      • Exhibit 47: Data Table on Market opportunity by Type ($ billion)

    7 Market Segmentation by End-user

    • 7.1 Market segments
      • Exhibit 48: Chart on End-user - Market share 2023-2028 (%)
      • Exhibit 49: Data Table on End-user - Market share 2023-2028 (%)
    • 7.2 Comparison by End-user
      • Exhibit 50: Chart on Comparison by End-user
      • Exhibit 51: Data Table on Comparison by End-user
    • 7.3 Hospitals - Market size and forecast 2023-2028
      • Exhibit 52: Chart on Hospitals - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 53: Data Table on Hospitals - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 54: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
      • Exhibit 55: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
    • 7.4 Clinics - Market size and forecast 2023-2028
      • Exhibit 56: Chart on Clinics - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 57: Data Table on Clinics - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 58: Chart on Clinics - Year-over-year growth 2023-2028 (%)
      • Exhibit 59: Data Table on Clinics - Year-over-year growth 2023-2028 (%)
    • 7.5 Others - Market size and forecast 2023-2028
      • Exhibit 60: Chart on Others - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 61: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 62: Chart on Others - Year-over-year growth 2023-2028 (%)
      • Exhibit 63: Data Table on Others - Year-over-year growth 2023-2028 (%)
    • 7.6 Market opportunity by End-user
      • Exhibit 64: Market opportunity by End-user ($ billion)
      • Exhibit 65: Data Table on Market opportunity by End-user ($ billion)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 67: Chart on Market share by geography 2023-2028 (%)
      • Exhibit 68: Data Table on Market share by geography 2023-2028 (%)
    • 9.2 Geographic comparison
      • Exhibit 69: Chart on Geographic comparison
      • Exhibit 70: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2023-2028
      • Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
      • Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
    • 9.4 Europe - Market size and forecast 2023-2028
      • Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
      • Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
    • 9.5 Asia - Market size and forecast 2023-2028
      • Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
      • Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
      • Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
      • Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • 9.7 US - Market size and forecast 2023-2028
      • Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
      • Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
    • 9.8 Germany - Market size and forecast 2023-2028
      • Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
      • Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
    • 9.9 Japan - Market size and forecast 2023-2028
      • Exhibit 95: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 96: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 97: Chart on Japan - Year-over-year growth 2023-2028 (%)
      • Exhibit 98: Data Table on Japan - Year-over-year growth 2023-2028 (%)
    • 9.10 UK - Market size and forecast 2023-2028
      • Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%)
      • Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%)
    • 9.11 Canada - Market size and forecast 2023-2028
      • Exhibit 103: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 104: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 105: Chart on Canada - Year-over-year growth 2023-2028 (%)
      • Exhibit 106: Data Table on Canada - Year-over-year growth 2023-2028 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 107: Market opportunity by geography ($ billion)
      • Exhibit 108: Data Tables on Market opportunity by geography ($ billion)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 109: Impact of drivers and challenges in 2023 and 2028
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 111: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 112: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 113: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 114: Matrix on vendor position and classification
            • 12.3 Andre Prost Inc
              • Exhibit 115: Andre Prost Inc - Overview
              • Exhibit 116: Andre Prost Inc - Product / Service
              • Exhibit 117: Andre Prost Inc - Key offerings
            • 12.4 Aurobindo Pharma Ltd.
              • Exhibit 118: Aurobindo Pharma Ltd. - Overview
              • Exhibit 119: Aurobindo Pharma Ltd. - Product / Service
              • Exhibit 120: Aurobindo Pharma Ltd. - Key offerings
            • 12.5 Boyd Pharmaceuticals
              • Exhibit 121: Boyd Pharmaceuticals - Overview
              • Exhibit 122: Boyd Pharmaceuticals - Product / Service
              • Exhibit 123: Boyd Pharmaceuticals - Key offerings
            • 12.6 CVS Health Corp.
              • Exhibit 124: CVS Health Corp. - Overview
              • Exhibit 125: CVS Health Corp. - Business segments
              • Exhibit 126: CVS Health Corp. - Key offerings
              • Exhibit 127: CVS Health Corp. - Segment focus
            • 12.7 FISHERMANSFRIEND.COM
              • Exhibit 128: FISHERMANSFRIEND.COM - Overview
              • Exhibit 129: FISHERMANSFRIEND.COM - Product / Service
              • Exhibit 130: FISHERMANSFRIEND.COM - Key offerings
            • 12.8 GRETHERS USA
              • Exhibit 131: GRETHERS USA - Overview
              • Exhibit 132: GRETHERS USA - Product / Service
              • Exhibit 133: GRETHERS USA - Key offerings
            • 12.9 iNova Pharmaceuticals
              • Exhibit 134: iNova Pharmaceuticals - Overview
              • Exhibit 135: iNova Pharmaceuticals - Product / Service
              • Exhibit 136: iNova Pharmaceuticals - Key offerings
            • 12.10 Johnson and Johnson
              • Exhibit 137: Johnson and Johnson - Overview
              • Exhibit 138: Johnson and Johnson - Business segments
              • Exhibit 139: Johnson and Johnson - Key news
              • Exhibit 140: Johnson and Johnson - Key offerings
              • Exhibit 141: Johnson and Johnson - Segment focus
            • 12.11 Lanes Health
              • Exhibit 142: Lanes Health - Overview
              • Exhibit 143: Lanes Health - Product / Service
              • Exhibit 144: Lanes Health - Key offerings
            • 12.12 Mondelez International Inc.
              • Exhibit 145: Mondelez International Inc. - Overview
              • Exhibit 146: Mondelez International Inc. - Business segments
              • Exhibit 147: Mondelez International Inc. - Key news
              • Exhibit 148: Mondelez International Inc. - Key offerings
              • Exhibit 149: Mondelez International Inc. - Segment focus
            • 12.13 PINE BROS LLC.
              • Exhibit 150: PINE BROS LLC. - Overview
              • Exhibit 151: PINE BROS LLC. - Product / Service
              • Exhibit 152: PINE BROS LLC. - Key offerings
            • 12.14 Prestige Consumer Healthcare Inc.
              • Exhibit 153: Prestige Consumer Healthcare Inc. - Overview
              • Exhibit 154: Prestige Consumer Healthcare Inc. - Business segments
              • Exhibit 155: Prestige Consumer Healthcare Inc. - Key offerings
              • Exhibit 156: Prestige Consumer Healthcare Inc. - Segment focus
            • 12.15 Procter and Gamble
              • Exhibit 157: Procter and Gamble - Overview
              • Exhibit 158: Procter and Gamble - Business segments
              • Exhibit 159: Procter and Gamble - Key offerings
              • Exhibit 160: Procter and Gamble - Segment focus
            • 12.16 Reckitt Benckiser Group Plc
              • Exhibit 161: Reckitt Benckiser Group Plc - Overview
              • Exhibit 162: Reckitt Benckiser Group Plc - Business segments
              • Exhibit 163: Reckitt Benckiser Group Plc - Key offerings
              • Exhibit 164: Reckitt Benckiser Group Plc - Segment focus
            • 12.17 Ricola Group AG
              • Exhibit 165: Ricola Group AG - Overview
              • Exhibit 166: Ricola Group AG - Product / Service
              • Exhibit 167: Ricola Group AG - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 168: Inclusions checklist
                • Exhibit 169: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 170: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 171: Research methodology
                • Exhibit 172: Validation techniques employed for market sizing
                • Exhibit 173: Information sources
              • 13.5 List of abbreviations
                • Exhibit 174: List of abbreviations

              Research Methodology

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              Interested in this report?

              Get your sample now to see our research methodology and insights!

              Download Now

              Frequently Asked Questions

              Throat Pastilles and Cough Drops market growth will increase by $ 1.25 bn during 2024-2028.

              The Throat Pastilles and Cough Drops market is expected to grow at a CAGR of 3.72% during 2024-2028.

              Throat Pastilles and Cough Drops market is segmented by Type( Hard tablet lozenges, Soft tablet lozenges, Compressed tablet lozenges) End-user( Hospitals, Clinics, Others, Rest of World (ROW))

              Andre Prost Inc, Aurobindo Pharma Ltd., Boyd Pharmaceuticals, CVS Health Corp., FISHERMANSFRIEND.COM, GRETHERS USA, iNova Pharmaceuticals, Johnson and Johnson, Lanes Health, Maneesh Pharmaceuticals Ltd, Mondelez International Inc., PINE BROS LLC., Prestige Consumer Healthcare Inc., Prince Care Pharma Pvt Ltd, Procter and Gamble, Quantum Health, Reckitt Benckiser Group Plc, Ricola Group AG, STADA Arzneimittel AG, Walgreens Boots Alliance Inc. are a few of the key vendors in the Throat Pastilles and Cough Drops market.

              North America will register the highest growth rate of 34% among the other regions. Therefore, the Throat Pastilles and Cough Drops market in North America is expected to garner significant business opportunities for the vendors during the forecast period.

              US, Canada, Germany, UK, Japan

              • Advantages over other dosage formsOral dosage forms differ from and have advantages over other dosage forms such as parenteral and intravenous. Oral dosage forms are economical is the driving factor this market.
              • safe is the driving factor this market.
              • and are the easiest route of drug administration. Similarly is the driving factor this market.
              • their toxicity (if any) is delayed due to the delayed onset of action is the driving factor this market.
              • which permits easier recovery than that in the case of other dosage forms. In the case of other dosage forms such as parenteral is the driving factor this market.
              • there are several requirements for the administration of drugs is the driving factor this market.
              • such as the requirement of aseptic techniques in the production is the driving factor this market.
              • compounding is the driving factor this market.
              • and handling of the product is the driving factor this market.
              • as well as the requirement of trained personnel for administration followed by psychological pain associated with the injection. Also is the driving factor this market.
              • injectables have a higher cost as compared to solid dosage forms. Owing to the advantages of oral dosage forms is the driving factor this market.
              • throat pastilles and cough drops are highly preferred by patients. Throat pastilles and cough drops are known as lozenges is the driving factor this market.
              • which are one of the most widely used solid dosage forms for cough relief and sore throat. They contain drugs or herbal ingredients in a flavored and sweetened base and are intended to treat local irritation or infection of the mouth and pharynx. They are also used for systemic drug absorption through the buccal linings or when swallowed. Currently is the driving factor this market.
              • several types of lozenges are available in the market is the driving factor this market.
              • which are capable of providing several advantages and relief from symptoms of diseases. For example is the driving factor this market.
              • nicotine lozenges are used to help smokers quit smoking; linctagon lozenges contain the active ingredient pelargonium sidoides and eucalyptus oil is the driving factor this market.
              • which soothe a sore and irritated throat; fungilin lozenges are used to treat infections in or around the mouth; flurbiprofen lozenges are used to relieve pain and inflammation in the throat; and ACTIQ lozenges are used to relieve breakthrough pain in people already receiving opioid painkillers. These lozenges can be given to patients who have difficulty swallowing is the driving factor this market.
              • and the administration is non-invasive. Therefore is the driving factor this market.
              • these advantages of lozenges have increased patient propensity toward these easily available dosage forms is the driving factor this market.
              • thereby driving the global throat pastilles and cough drops market growth during the forecast period. is the driving factor this market.

              The Throat Pastilles and Cough Drops market vendors should focus on grabbing business opportunities from the Hard tablet lozenges segment as it accounted for the largest market share in the base year.